Patients should not discontinue statins in favour of GLP-1 therapy for cholesterol management without explicit guidance from their healthcare provider, as this could compromise cardiovascular risk reduction
Food and Drug Administration (FDA) This could include drugs such as semaglutide (the active ingredient in Ozempic and Wegovy), According to the FDAs announcement, the organization is asking for submitted comments for or against this decision by the end of June 2026 before making their final determination
GLP-1 vs Ozempic for Weight Loss Whats the Difference
However, this offer only applies to vials of the drug, not the autoinjector pens
Most seniors are on many other medications, and they've got their pill case, and they use that every day, and this will just fit right into that without any extra thought." Ricks said Lilly is working closely with the government to prepare, and he's confident that Humana, which will process prescription requests, will do a good job
What can patients taking weight loss medications expect
